Cargando…
Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST Study at 16 weeks
Morning home blood pressure (BP) levels are more closely associated with cardiovascular risk than clinic BP levels. However, control of morning home BP has been worse than that of clinic BP in clinical practice. We examined the effects of olmesartan-based treatment using data (n=21 341) from the fir...
Autores principales: | Kario, K, Saito, I, Kushiro, T, Teramukai, S, Ishikawa, Y, Hiramatsu, K, Kobayashi, F, Shimada, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831295/ https://www.ncbi.nlm.nih.gov/pubmed/23863805 http://dx.doi.org/10.1038/jhh.2013.68 |
Ejemplares similares
-
Persistent olmesartan-based blood pressure–lowering effects on morning hypertension in Asians: the HONEST study
por: Kario, Kazuomi, et al.
Publicado: (2016) -
Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study
por: Saito, Ikuo, et al.
Publicado: (2013) -
Effects of Olmesartan‐Based Treatment on Masked, White‐Coat, Poorly Controlled, and Well‐Controlled Hypertension: HONEST Study
por: Kario, Kazuomi, et al.
Publicado: (2014) -
Enhanced Blood Pressure–Lowering Effect of Olmesartan in Hypertensive Patients With Chronic Kidney Disease–Associated Sympathetic Hyperactivity: HONEST Study
por: Kario, Kazuomi, et al.
Publicado: (2013) -
Differences between clinic blood pressure and morning home blood pressure, as shown by Bland–Altman plots, in a large observational study (HONEST study)
por: Shimada, Kazuyuki, et al.
Publicado: (2015)